Global Enteric Disease Testing Market

The global enteric disease testing market was valued at USD 3.832 billion in 2020 and is expected to reach USD 5.0123 billion with a CAGR of 3.8% during the forecast period, 2021-2027. The increasing use of enteric disease testing, rising molecular diagnostic technology, and advancements in disease testing technologies are the major factors restoring the growth of the global enteric disease testing market. Furthermore, an increase in involvement from the governments to advance the living standard in individuals is among the key factors likely over the forecast period to drive the global market’s growth for enteric disease testing.

What is Enteric Disease Testing?

The enteric disease is caused by the entry of microorganisms into the body through the mouth. These diseases can be transmitted through contaminated food and water and the feces of infected people and animals. Symptoms of enteric disease are nausea, vomiting, abdominal cramps, and loss of appetite, leading to a loss of essential fluids and nutrients from the body. The enteropathy infections range from asymptomatic and mild to severe symptoms with abdominal cramps, nausea, vomiting, and loss of appetite. Severe cases and symptoms can be fatal due to the severe loss of water and essential nutrients from the body.

Growth Driver

Growing testing technological development

There is increasing demand for various testing technologies to boost the enteric disease testing market. The traditional methods of diagnosis depend on the techniques of the culture and demand the expertise of trained staff, making it a time-consuming process. The advent of molecular diagnostics and various diagnostic technologies has transformed the disease testing landscape in the last decade. An increase in mortality due to these diseases and the cost-effectiveness of technically innovative procedures are expected to boost the market.

Opportunities

Growing awareness among Enteric Disease

Growing awareness about unsafe drinking water, sanitation and drainage systems and unhygienic living conditions can significantly reduce the risk of enteric diseases. Growing awareness among people of the benefits of early diagnosis is driving the enteric disease testing market. Furthermore, numerous national or international agencies, such as the World Health Organization and the United Nations Children’s Funds, are conducting awareness programs and setting up healthcare camps in different countries to promote the testing of enteric diseases, and various prominent companies are focusing on the commercialization of innovative testing technology in enteric diseases, which helps to drive the growth of the market.

Restraints

Lack of awareness about the Enteric Disease

Lack of awareness concerning enteric disease, especially in emerging economies, is likely to delay the growth of the global enteric disease testing market. Furthermore, most of the people who are infected with the enteric disease are show mild symptoms and asymptotic. The minor nature of pathogens lets people ignore their diagnosis. Although the minor nature or asymptomatic of enteric diseases is good for people, on the other hand, it is considered as one of the major restraints affecting the growth of the global enteric disease testing market.

Pre-Covid-19 impact on the global Enteric Disease Testing market

The increasing number of individuals infected with these bacteria supports the growth of the enteric disease testing industry. According to the World Health Organization (WHO) 2018 report, an estimated 11–20 million people infected with typhoid fever have life-threatening infections caused by Salmonella Typhi’s bacterium. Additionally, the increasing need for understanding disease fuels the development of new treatments for patients, resulting in the gradual increase of enteric disease testing. This fueled the expansion of the enteric disease testing market in the pre-covid-19 period.

Covid-19 impact on the global Enteric Disease Testing market

The pandemic of COVID-19 has developed in lockdown across regions, with line limitations and a breakdown of transportation organizations. Furthermore, the financial susceptibility of the enteric disease testing devices market is a lot higher than past flare-ups like the extreme intense respiratory condition (SARS), Ebola, bird influenza, pig influenza, and avian influenza, inferable from the increasing number of contaminated persons and the susceptibility to the end of the crisis. With the rapid rise of cases, the global enteric disease testing devices market is influenced by multiple perspectives. The accessibility of the workforce will certainly disrupt the inventory network of the global enteric disease testing equipment market, as the lockdown and spread of the infection will force people to stay inside. The performance of enteric disease testing equipment and the transportation of products are related to it. When the assembly stops moving, so does the transport and branch network. Items that require a lot of work, the stacking and unloading of raw materials and results, are also greatly affected because of the Covid -19. From the entry area of the assembly plant to the distribution center or stock room to the end customer, i.e., storage room or distribution center to the end customer, i.e., The entire network of application companies and existing enteric disease testing equipment is at serious risk as a result of episodes.

Post Covid-19 impact on the global Enteric Disease Testing market

A factor that drives the growth of the enteric disease testing market is the execution of strict regulations related to contaminant detection and growth in consumer awareness, leading to an upsurge in contamination in food. To address enteric disease concerns caused by foodborne illness, the concern among consumers is estimated to grow for the safety of food products, and there is a high adoption rate for testing technologies and laboratories across the world. The demand for enteric disease testing will rise in the forecast period. Furthermore, the pandemic situations caused by the outbreak of COVID-19 have increased the demand for rapid testing for food manufacturers and producers to test a reasonable number of samples, thereby increasing the adoption of testing technologies.

Disease type Segmental Analysis

Based on the Disease type, the global enteric disease testing market is segmented into bacterial (E-coli, C. difficlie, H. pylori, campylobacteriosis, cholera, salmonellosis, and shigellosis), viral (rotavirus, and norovirus), parasitic (amebiasis, cryptosporidiosis, and giardiasis). The bacterial segment captured the largest market share in 2020 and is likely to grow critically during the forecast period, 2021-2027. E. coli infection is the leading bacteria that cause enteric disorders among children.

Technology Segmental Analysis

The global enteric disease testing market is categorized into molecular diagnostics, differential light scattering, liposomes, flow cytometry, diagnostic imaging, gel microdroplets, immunoassays, information technology, artificial intelligence, chromatography, etc. The molecular diagnostic segment holds the largest market share in 2020 and is expected to grow significantly during the forecast period, 2021-2027. The segment’s growth is attributed to molecular diagnostics technology is the developing technology in enteric diseases, and it is expected to be the fastest-growing compared to other technologies.

Region Segmental Analysis

The global Enteric Disease Testing market is characterized by North America, Europe, Asia Pacific, South America, and Middle East & Africa. Asia- Pacific has the largest market share in 2020 and is estimated to grow significantly during the forecast period, 2021-2027. This growth is concerned with the growing increase in the migration of people from rural areas to urban. Lack of proper hygiene and sanitation among individuals, especially in countries like India and China, is expected to propel the regional market’s growth in the forecast period.

Competitor Analysis

Companies include Alere Inc, Bio-Rad Laboratories, Quest Diagnostics, Becton Dickinson and Company, Cepheid Inc, DiaSorin, Meridian Biosciences, Trinity Biotech, Coris Bio Concept, Bio Merieux, Biomerica, Tech LAB Inc, Other are the key players in the global Enteric Disease Testing market. Key Stakeholders

• Market research and consulting firms
• Industry associations
• Global enteric disease testing manufacturing firm
• Global enteric disease testing providers
• Local Governments
• Regulatory bodies
• Suppliers
• Retailers

Scope of the Report

Report Attribute	Details
Market Size Value in 2020	USD 3.832 Billion
The revenue forecast in 2027	USD 5.0123 Billion
Growth Rate	CAGR of 3.8% from 2020 to 2027.
Historical data	2017-2019
Forecast period	2021 – 2027
Region covered	North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Key companies Profiled	Alere Inc, Bio-Rad Laboratories, Quest Diagnostics, Becton Dickinson and Company, Cepheid Inc, DiaSorin, Meridian Biosciences, Trinity Biotech, Coris Bio Concept, Bio Merieux, Biomerica, Tech LAB Inc, Other players

Market Modelling

By Disease type

• Bacterial
  • E-coli
  • Difficlie
  • Pylori
  • Campylobacteriosis
  • Cholera
  • Salmonellosis
  • Shigellosis
• Viral
  • Rotavirus
  • Norovirus
• parasitic
  • Amebiasis
  • Cryptosporidiosis
  • Giardiasis

By technology

• Molecular diagnostics
• Differential light scattering
• Liposomes
• Flow cytometry
• Diagnostic imaging
• Gel microdroplets
• Immunoassays
• Information technology
• Artificial intelligence
• Chromatography
• Other

By Region

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Drone Logistics and Transportation Market

Global Synthetic Rubber Market

5G in Healthcare Market

Automated Optical Inspection Market

Global Drone Battery Market

Single Cell Multi-Omics Market

Asia-Pacific Liquid Chromatography Market

Small Scale LNG Market

Middle East and Africa Condensing Unit Market

Automated Optical Inspection Market